CURRICULUM VITAE



CURRICULUM VITAE

Michael Gabay PharmD, JD, BCPS, FCCP

PERSONAL INFORMATION:

ADDRESS: Office: University of Illinois at Chicago

Department of Pharmacy Practice

College of Pharmacy

833 S Wood St, Room B12

Chicago, IL 60612-7230

(312) 413-3977

mgabay@uic.edu

LICENSURE/CERTIFICATION:

Minnesota #116347-0

Illinois #051-286600

Board Certified Pharmacotherapy Specialist: 2000-2007

Recertification: 2007, 2014

Illinois Bar Member since May 2008: Inactive

EDUCATION:

2003-2007 Doctor of Jurisprudence

Loyola University of Chicago College of Law

2001 Medical Editing

University of Chicago Center for Continuing Studies

1998-1999 Drug Information Specialty Residency

University of Illinois at Chicago Medical Center

1997-1998 Pharmacy Practice Residency

Fairview-University (University of Minnesota) Medical Center

1993-1997 Doctor of Pharmacy

University of Minnesota College of Pharmacy

Bachelor of Science in Pharmacy

University of Minnesota College of Pharmacy

1990-1993 Pre-Pharmacy Curriculum

University of Wisconsin – La Crosse

CURRENT APPOINTMENT (% EFFORT):

30% Administration

35% Business development/entrepreneurial activity including completion of work involving revenue generating agreements

15% Teaching including formal instructional activity, precepting, and mentoring

10% Scholarly activity

5% Indirect patient care through drug information requests

5% Professional and public service

ACADEMIC APPOINTMENTS:

2020-Present Clinical Professor

Department of Pharmacy Practice, University of Illinois at Chicago

2012-2020 Residency Director, PGY2 Drug Information UIC

Department of Pharmacy Practice, University of Illinois at Chicago

2014-2016 Residency Director, PGY2 Drug Information UIC/Takeda Pharmaceuticals

Department of Pharmacy Practice, University of Illinois at Chicago

2010-Present Clinical Associate Professor

Department of Pharmacy Practice, University of Illinois at Chicago

1999-2009 Clinical Assistant Professor

Department of Pharmacy Practice, University of Illinois at Chicago

1998-1999 Clinical Associate

Department of Pharmacy Practice, University of Illinois at Chicago

1997-1998 Clinical Instructor

Department of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota

PROFESSIONAL EXPERIENCE:

2007-Present Director, Drug Information Group and Prior Authorization Programs

Department of Pharmacy Practice, University of Illinois at Chicago

2006-2007 Interim Director, Drug Information Group

Department of Pharmacy Practice, University of Illinois at Chicago

2003-2005 Assistant Director, Drug Information Group

Department of Pharmacy Practice, University of Illinois at Chicago

1999-Present Clinical Pharmacist, Drug Information

University of Illinois at Chicago

1998-1999 On-Call Pharmacist

University of Illinois at Chicago Medical Center

1997-1998 Central Pharmacist

Fairview-University Medical Center

1995-1996 Pharmacy Assistant

Boynton Health Service – University of Minnesota

ACADEMIC TEACHING:

Evidence-Based Medicine (PHAR 440), College of Pharmacy, University of Illinois at Chicago

Lecturer/Team-Based Learning Leader. 2018-2019

Lectures presented:

Evidence-based medicine I and II

Team-based learning recitation:

Applying evidence-based medicine

Introduction to Drug Information (PHAR 438), College of Pharmacy, University of Illinois at Chicago

Course Coordinator. 2017; 2019.

Lecturer/Recitation Leader. 2017-2019

Lectures presented:

Introduction to drug information resources

Systematic approach

Tertiary resources I and II

Literature Evaluation and Evidence-Based Medicine (PHAR 6222) – Chicago State University College of Pharmacy

Course Coordinator. 2016

Lecturer/Recitation Leader. 2010-2016.

Lectures presented:

Tertiary references – General drug/disease states

Tertiary references – Adverse drug reactions/drug-drug interactions

Secondary references

Medical writing/plagiarism

Approach to drug information requests

How to conduct a Medline search

Evidence-based medicine I and II

Meta-analysis

Regulatory issues

Drug Information and Statistics (PHAR 455), College of Pharmacy, University of Illinois at Chicago

Course Coordinator. 2004

Co-Coordinator. 2003

Lecturer/Recitation Leader. 1998-2017.

Lectures presented:

General disease state resources

Drug interaction resources

Adverse drug reaction resources

Herbal references

Internet information sources

Writing skills and plagiarism

Drugs in pregnancy and lactation

Fee for service

Application of the systematic approach

Ethics

Primary literature introduction

Micromedex information system

Randomization, samples, and distribution

Tertiary references

Literature evaluation series

Plasma-Derived and Recombinant Therapeutics (PMPR 385), College of Pharmacy, University of Illinois at Chicago

Lecturer. 2003-2010

Lectures presented:

Therapeutic uses of intravenous immunoglobulin and hyperimmunes

Viral safety and plasma-derived products

Nurse Practitioner Program. College of Nursing, University of Illinois at Chicago

Lecturer: 2001-2003

Lectures presented:

Community-acquired pneumonia

Urinary tract infections

Sinusitis

Ambulatory care experiential course (PMPR 371), College of Pharmacy, University of Illinois at Chicago

Course facilitator. 1998

Primary Preceptor for PGY1 residents. Drug Information rotation. University of Illinois at Chicago. 1999 to 2004.

PGY1 residents included:

2003-2004: Geanina Alecsa, Courtney Eckhoff, Azzah Jeddy, Tiffany Kaiser, Keri Kim, Karen King, Kathryn Momary, Jennifer Morris, Katherine Pham, Asia Werbowsky, Joanne Witsil

2002-2003: Nicole Boyea, Renee Costianis, Gina DiBona, Cristina Fernandez, Sonia Ibrahim, Tiffenee Jones, Lois Lee, Neera Mahal, Carissa Mancuso, Jessica Tilton, Joene Van Cranenebroeck, Candice Wong

2001-2002: Amber Beitelshees, Colleen Doherty, Mitra Habibi, Rupali Jain, Kinnari Khorona, Phillipe Mentler, John Patka, Thuy Pham, Leigh Ann Reed, Heather Richardson, Natasa Stevkovic, Maria Tanzi, Mandy Walker

2000-2001: Shana Gunderson, Arom Jedsadayanmata, Janelle Johnson, Ada Koch, Greg Malat, Jennifer Marceille, Vanessa Mategrano, Jeff Mucksavage, Nima Patel, Jennifer Pon

1999-2000: Alison Einhorn, Sol Farias, Mimi Marler, Jayne Stigler, Emilio Perez, Peter Liang, Aaron Hoffman, Jennifer Collura, Rebecca Lau, Jody Sheehan

Residency Program Director for ASHP-accredited UIC/Takeda PGY2 Drug Information Residency: 2014 to 2016

Residency Program Director for ASHP-accredited UIC PGY2 Drug Information Residency: 2011 to present

UIC PGY2 residents included:

2019-2020: Kaitlin Miles

2018-2019: Amanda Gerberich

2017-2018: Elana Nelson

2016-2017: Laura Koppen

2015-2016: Katherine Zych, Kristin Kaneshiro

2014-2015: Carol Poskay, Samantha Spencer

2013-2014: Aparna Reddy

2012-2013: Shadi Ghaibi, Michelle Bryson

2011-2012: Lara Ellinger

UIC/Takeda PGY2 residents included:

2015-2016: Patricia Hartke

2014-2015: Nicole Mueller

Drug Information Management rotation preceptor for PGY2 residents in Drug Information. University of Illinois at Chicago. 1999 to 2011.

PGY2 residents included:

2010-2011: Sheri Van Osdol

2009-2010: Irene Hong, Heather Ipema

2003-2004: Carissa Mancuso

2000-2001: Huong Luu

1999-2000: Miriam Ansong, Meghan Shannon

Preceptor. Doctor of Pharmacy candidates. Drug Information rotation. University of Illinois at Chicago. 1998 to present.

Doctor of Pharmacy candidates included:

2014-2015: Ricky Li

2008-2009: Andrius Cepenas, Carolyn Szigethy

2006-2007: Georgia Tsiodras

2005-2006: Christine Dunne, Shaya Reddy, Brenda Beuth, Nikolai Johnson

2003-2004: Annu Bhai, Jamelah Farraj, Kathy Fit, Lisa Stemplewski

2002-2003: Susie Min

College of Pharmacy Phlames Family Advisor: 2017- present

Students included: Justina Kim – 2018 graduate

Patricia Asonye – 2019 graduate

Krystian Wojdyla – 2020 PharmD candidate

Krupa Patel – 2021 PharmD candidate

Heejin Hur – 2022 PharmD candidate

Matthew Hart – 2023 PharmD candidate

PUBLICATIONS:

JOURNAL ARTICLES (PEER-REVIEWED):

Lee M, Saseen J, Beckman E, Coon S, Gabay M, Japs K, Mangan B, McBane S, See S. ACCP Commentary. Expanding the pharmacist’s scope of practice at the state level: support for board certification within the credentialing process. J Am Coll Clin Pharm. 2019 [In Press].

Sarna K, Griffin T, Tarlov E, Gerber BS, Gabay M, Suda KJ. Trends in gender composition on editorial boards in leading medicine nursing, and pharmacy journals. J Am Pharm Assoc. 2020. pii: S1544-3191(19)30609-0. doi: 10.1016/j.japh.2019.12.018. [Epub ahead of print]

Gabay M. The Orphan Drug Act: an appropriate approval pathway for treatments of rare diseases? Hosp Pharm. 2019;54(5):283-284.

Gabay M, Hertig JB, Degnan D, Burger M, Yaniv A, McLaughlin M, Moody ML. Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems – 2018. Am J Health-Syst Pharm. 2019. Dec 7. pii: zxz277. doi: 10.1093/ajhp/zxz277. [Epub ahead of print]

Sinnett MJ, Wiest S, Gabay M, Rodriguez R, Afanasjeva J, Fanikos J, Cunningham F, Burk M, Hayes G. ASHP guidelines on medication use evaluation. [Submitted].

Nathan J, Grossman S, Ness G, Gabay M, Ipema H, Tierno H. Update on the status of drug information centers in the United States. Am J Health-Syst Pharm. 2020;77(1):33-38.

Gabay M. A rapid review of right-to-try. Hosp Pharm. 2018;53(4):234-235.

Gabay M. Pharmacist gag clauses. Hosp Pharm. 2018;53(6):376-377.

Gabay M. The Prescription Drug User Fee Act: cause for concern? Hosp Pharm. 2018;53(2):88-89.

Spencer S, Ipema H, Hartke P, Krueger C, Rodriguez R, Gross AE, Gabay M. Intravenous push administration of antibiotics: literature and considerations. Hosp Pharm. 2018;53(3):157-169.

Gabay M. Direct and indirect remuneration fees: the controversy continues. Hosp Pharm. 2017;52(11):740-741.

Gabay M. Biosimilar substitution laws. Hosp Pharm. 2017;52(8):544-545.

Gabay M. The evolution of drug information centers and specialists. Hosp Pharm. 2017;52(7):452-453.

Gabay M. 21st Century Cures Act. Hosp Pharm. 2017;52(4):264-265.

Gabay M, Smith JA, Chavez ML, et al. ACCP white paper on natural products. Pharmacotherapy. 2017 Jan;37(1):e1-e15. doi: 10.1002/phar.1874. Epub 2016 Dec 9.

Gabay M. Increasing access to naloxone and legal issues. Hosp Pharm. 2016;51(8):633-634.

Gabay M. Drug prices: is there a need for transparency? Hosp Pharm. 2016;51(2):132-133.

Gabay M. FAST Generics Act of 2015. Hosp Pharm. 2016;51(1):42-43.

Gabay M. Regulation of internet pharmacies: a continuing challenge. Hosp Pharm. 2015;50(8):681-682.

Gabay MP, Wirth SM, Stachnik JM, Overley CL, Long KE, Bressler LR, Villano JL. Oral targeted therapies and central nervous system (CNS) metastases. CNS Drugs. 2015;29(11):935-952.

Gabay M. Prescription drug monitoring programs. Hosp Pharm. 2015;50(4):277-278.

Gabay M. Providing feedback to colleagues: a continual challenge. Hosp Pharm. 2015;50(4):259-260.

Ghaibi S, Ipema H, Gabay M. ASHP guidelines on the pharmacist’s role in providing drug information. Am J Health Syst Pharm. 2015;72(7):573-577.

Gabay M. USP : Handling hazardous drugs. Hosp Pharm. 2014;49(9):811-812.

Letarte N, Gabay MP, Bressler LR, Long KE, Stachnik JM, Villano JL. Analyzing temozolomide medication errors: potentially fatal. J Neurooncol. 2014;120(1):111-115.

Gabay M. A step forward: review of the new California provider status law. Hosp Pharm. 2014;49(5):435-436.

Gabay M. Federal controlled substances act: dispensing requirements, electronic prescriptions, and fraudulent prescriptions. Hosp Pharm. 2014;49(3):244-246.

Gabay M. Federal controlled substances act: ordering and recordkeeping. Hosp Pharm. 2013;48(11):919-921.

Gabay M. Federal controlled substances act: controlled substances prescriptions. Hosp Pharm. 2013;48(8):644-645.

Gabay M. The federal controlled substances act: schedules and pharmacy registration. Hosp Pharm. 2013;48(6):473-474.

Gabay M. Expanding the definition of nonprescription drugs: potential impact on pharmacists. Hosp Pharm. 2013;48(3):198-199.

Gabay M, Boucher B. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy. 2013;33(9):935-955.

Gabay M. Resource conservation and recovery act: management of pharmaceutical waste. Hosp Pharm. 2012;47(10):769-770.

Gabay M. Tech-check-tech: an overview. Hosp Pharm. 2012;47(6):444-445.

Gabay M. Drug importation: where do we stand? Hosp Pharm. 2012;47(2):110-111.

Phillips J, Gabay M, Ficzere C, Ward K. Instructional methods for drug information, literature evaluation, and biostatistics: survey of US pharmacy schools. Ann Pharmacother. 2012;46(6):793-801.

Gabay M, Thakkar JP, Stachnik JM, Woelich S, Villano JL. Intra-CSF administration of chemotherapy medications. Cancer Chemother Pharmacol. 2012;70(1):1-15.

Gabay M. FDA citizen petition process. Hosp Pharm. 2011;46(8):572-573.

Hong IS, Ipema HJ, Gabay MP, Lodolce AE. Medication repurposing: new uses for old drugs. J Pharm Technol. 2011;27(3):132-140.

Gabay M. Pharmacist conscience clauses: continuing debate. Hosp Pharm. 2011;46(5):330-331.

Gabay M. Emily’s law: requiring minimum education and training standards for pharmacy technicians. Hosp Pharm. 2011;46(2):103-104.

Gabay M. Academic detailing and the IDEA act. Hosp Pharm. 2010;45(11):839-840.

Stachnik J, Gabay M. Emerging role of aripiprazole for treatment of irritability associated with autistic disorder in children and adolescents. Adolescent Health Med Ther. 2010;1:105-114.

Mancuso CE, Gabay MP, Steinke LM, Vanosdol SJ. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza. Ann Pharmacother. 2010;44(7-8):1240-1249.

Hong I, Gabay M, Lodolce A. Safety concerns involving transdermal patches and magnetic resonance imaging. Hosp Pharm. 2010;45(10):771-778.

Sanborn M, Gabay M, Moody ML. The safety of intravenous drug delivery systems: update on current issues since the 1999 consensus development conference. Hosp Pharm. 2009;44(2):159-164.

Gabay M, Martius K. Comparative evaluation of collapsible versus semi-rigid intravenous containers. Technology Health Care. 2008;16(6):429-435.

Gabay M. Absorbable hemostatic agents. Am J Health-Syst Pharm. 2006;63(13):1244-1253.

Mancuso C, Tanzi MG, Gabay MP. Paradoxical reactions to benzodiazepines – literature review and treatment options. Pharmacotherapy. 2004;24(9):1177-85.

Gabay MP, Costianis R. Restrictive drug distribution programs. Am J Health-Syst Pharm. 2003;60(15):1525-1530.

Stachnik J, Gabay MP. Continuous infusion of coagulation factor products. Ann Pharmacother. 2002;36(5):882-891.

Gabay MP, Jain R. Role of antibiotics for the prevention of cardiovascular disease. Ann Pharmacother. 2002;36(10):1629-1636.

Gabay MP. Galactogogues: medications that induce lactation. J Hum Lact. 2002;18(3):274-279.

Tanzi MG, Gabay MP. Association between honey consumption and infant botulism. Pharmacotherapy. 2002;22(11):1479-1483.

Gabay MP, Lodolce AE. Other reports of cerivastatin-induced rhabdomyolysis (letter). Arch Intern Med. 2001;161(21):2629.

Mategrano V, Gabay MP. Misoprostol for the prevention of postpartum hemorrhage. Ann Pharmacother. 2001;35(12):1648-1652.

Luu H, Gabay MP. Changes to the ACLS guidelines 2000: a continuing education course. KeePosted – the journal of the Illinois Council of Health-System Pharmacists. 2001;7:15-23.

BOOKS:

Gabay M. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning; 2015.

Gabay M, Krueger C, Banovic J, et al. 2010 Pharmacy Injectable Reference. 1st ed. Morristown (NJ): Dothen Press; 2010.

BOOK CHAPTERS:

Gabay M, McKeever AL. Introduction to drug information practice. In: Gabay M, editor. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning: 2015. P. 1-10.

Gabay M, Grando Holman Y. Academic detailing and industry relationships. In: Gabay M, editor. The Clinical Practice of Drug Information. 1st ed. Sudbury (MA): Jones & Bartlett Learning: 2015. P. 409-423.

Stachnik JM, Gabay MP. Coagulation disorders. In: Helms RA, Quan DJ, Herfindal ET, Gourley DR, editors. Textbook of Therapeutics. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 826-66.

Lodolce AE, Gabay MP. Bioterrorism. In: DePestel DD, Pass S, Ritchie DJ, editors. Pharmacotherapy Self Assessment Program. Book 5. 5th ed. Kansas City: American College of Clinical Pharmacy; 2005. p. 215-40.

TECHNICAL REPORTS (PEER-REVIEWED):

Beckman E, Coon S, Gabay M, Japs K, Lee M, Mangan B, McBane S, Saseen J, See S. ACCP Policy and Practice Advancement Issue Brief. State credentialing requirements for expanding pharmacists’ scope of practice. October 2018. . Accessed March 21, 2019.

Stachnik J, Gabay M. Biologics in pediatrics. In: Field M, Boat T, editors. Safe and Effective Medicines for Children. Institute of Medicine. 2012. . Accessed March 21, 2019.

Gabay MP. NK-1 antagonists. University Healthsystem Consortium Monograph Series. March 2009.

Gabay MP. Echinocandins. University Healthsystem Consortium Monograph Series. February 2007.

Gabay MP. Intravenous antifungals: amphotericin B and azole antifungals. University Healthsystem Consortium Monograph Series. January 2007.

Gabay MP. Aromatase inhibitors. University Healthsystem Consortium Monograph Series. May 2004.

Gabay MP. Oblimersen sodium. University Healthsystem Consortium Monograph Series. September 2004.

Gabay MP. Ibritumomab tiuxetan. University Healthsystem Consortium Monograph Series. May 2003.

Gabay MP. Intravenous immune globulins – class review. Rational Choice® Formulary. Premier, Inc. June 2003.

Gabay MP. Glycoprotein IIb/IIIa inhibitors – update. Rational Choice® Formulary. Premier, Inc. September 2003.

Gabay MP. COX-2 inhibitors: an update. University Healthsystem Consortium Monograph Series. October 2002.

Gabay MP. Nesiritide: an update. University Healthsystem Consortium Monograph Series. October 2002.

Gabay MP. Glycoprotein inhibitors: an update. University Healthsystem Consortium Monograph Series. September 2001.

TECHNICAL REPORTS (NON PEER-REVIEWED):

Gabay M. The Federal Controlled Substances Act: a primer for providers. September 26, 2019. . Accessed September 26, 2019.

Gabay M, Ciccone TG. Tramadol may increase hypoglycemia risk in patients. February 11, 2015. Available at: . Accessed March 21, 2019.

Gabay M, Ciccone TG. New ibuprofen skin patch being developed. December 14, 2015. Available at: . Accessed March 21, 2019.

Gabay M. Generate revenue with drug information services. Pharmacy Purchasing & Products. 2013;10(5);50.

Gabay M. Topical medications for the treatment of pain from sports injuries. Pain Medicine News. December 2011. 39-42.

Gabay M, Tanzi M. Medications for chronic pain – nonopioid analgesics. Practical Pain Management. 2011;11(3):92-92-95,100-101.

Papadakos P, Gabay M. The use of Brevital sodium. Reassessing options for short-acting anesthetics for short surgical procedures. Anesthesiology News. 2010.

Gabay M, Tanzi M. Soft tissue sarcomas of the extremities and trunk: a comprehensive review. Clinical Oncology News. 2010 Dec:1-8.

Gabay M, Tanzi M. Guidelines for the management of febrile neutropenia. Clinical Oncology News Special Edition. 2009(2):119-126.

Gabay MP. Obstetrics benchmarking project. University Healthsystem Consortium. February 2009.

Gabay MP. Handoff communications field brief. University Healthsystem Consortium. December 2008.

Gabay MP. Postoperative respiratory failure benchmarking project. University Healthsystem Consortium. December 2008.

Gabay MP. Ventilator management field brief. University Healthsystem Consortium. November 2008.

CONTINUING EDUCATION PROGRAMS:

Chopra T, Alexander J, Lodise T, Gabay M. Optimizing therapy in carbapenem-resistant infections. CME Zone. Applied Clinical Education. October 1, 2019. .

Clarke A, Levine TD, Ness S, Perez EE, Robins EH, Schleis T, Sobolevsky L, Vaughn LJ, Gabay M. Immunoglobulin therapy standards of practice: clinical guidelines and implementation. CME Zone. Applied Clinical Education. June 1, 2018. .

Baum SJ, Gabay M. When statins aren’t enough: PCSK9 inhibition in persistent hypercholesterolemia. CME Zone. Applied Clinical Education. February 8, 2019. .

Gabay M. Faculty chair. Power-Pak C.E. certificate program in medication therapy management. 2014 to present. .

Author of: Module 8. Cardiovascular conditions

Gabay M. Targeted therapies for lipid disorders: a review for the specialty pharmacist. Continuing education program for Vizient specialty pharmacists. April 2016.

Gabay M, MacLaren R. Optimizing blood utilization: strategies for improving hemostatic practices. Pharmacy Learning Network. CE newsletter. December 2011.

Gabay M. The federal controlled substances act: a primer for the pharmacy technician. Pharmacy Tech Topics. 2011;16(1):1-32.

Gabay M. Prevention of central line-associated bloodstream infections. 2010. Available at: .

Gabay M. Medication safety and the role of the pharmacy technician. Pharmacy Tech Topics. 2010;15(1):1-25.

Gabay M. Antiplatelet therapy following coronary artery stent placement - 2008. Available at: .

Gabay M. Medication errors: a focus on patient safety – 2007. Available at: .

Gabay M. Pharmacist’s perspective on immunizations. CEprn - A Pharmacy Continuing Education Program. February 2007.

Gabay MP, Tanzi MG. IGIV administration from the clinician’s perspective: therapeutic, formulation, and safety considerations. 2006.

Gabay M. Treatment of seizure disorders. CEprn – A Pharmacy Continuing Education Program. September 2005.

Gabay MP, Mancuso C. Treatment of systemic fungal infections part 1: update on antifungal therapy. Clinical Trends in Pharmacy Practice. 2004;18(1):1-20.

Gabay MP. Structured treatment interruptions: a therapeutic option for HIV? Clinical Trends in Pharmacy Practice. 2004;18(4):1-16.

Gabay MP, Leiby D. Emerging and migrating infectious risks in blood safety. Continuing education module for nursing and clinical laboratory professionals. 2003.

NEWSLETTERS:

Gabay MP. Status update on the national cardiovascular prevention guidelines – JNC 8, ATP 4, and Obesity 2. RxPress – University of Illinois Medical Center at Chicago. November/December 2011.

Gabay MP. N-acetylcysteine (NAC) and contrast-induced nephropathy: ACT trial results. RxPress – University of Illinois Medical Center at Chicago. November/December 2010.

Gabay MP. H1N1 influenza. RxPress – University of Illinois Medical Center at Chicago. September/October 2009.

Gabay MP. The effect of statins on cancer risk. RxPress – University of Illinois Medical Center at Chicago. January/February 2006.

Gabay MP. Dispensing errors involving Toprol XL. RxPress – University of Illinois Medical Center at Chicago. September/October 2005.

Gabay MP. Cardiac insufficiency bisoprolol study (CIBIS) III. RxPress – University of Illinois Medical Center at Chicago. September/October 2005.

Gabay MP. Depo-Provera contraceptive injection – new warnings regarding bone mineral density loss. RxPress - University of Illinois Medical Center at Chicago. November/December 2004.

Gabay MP. Updated guidelines for antiretroviral agents in pediatric patients: focus on adverse events. Rx Press - University of Illinois Medical Center at Chicago. November/December 2004.

Gabay MP. Oral erythromycin and risk of sudden cardiac death. RxPress – University of Illinois Medical Center at Chicago. September/October 2004.

Gabay MP. COX-2 inhibitors – cardiovascular and gastrointestinal safety. RxPress – University of Illinois Medical Center at Chicago. September/October 2004.

Gabay MP. Diphenhydramine and dextromethorphan for pediatric cough. RxPress – University of Illinois Medical Center at Chicago. July/August 2004.

Gabay MP. Health advisories on antidepressants and atypical antipsychotics. RxPress – University of Illinois Medical Center at Chicago. March/April 2004.

Gabay MP. High impact drug brief. Herceptin. University HealthSystem Consortium. Spring 1999.

Gabay MP. Ketorolac tromethamine (Toradol) and renal failure. TOPICS - Hennepin Regional Poison Center Newsletter. Vol. 10. No. 1. Summer 1997.

EDITOR:

Practical Pain Management. Editorial board member. 2011-Present.

Hospital Pharmacy. Contributing editor. 2010-Present.

RxPress. University of Illinois Medical Center at Chicago – bimonthly newsletter. 1998-Present.

JOURNAL/BOOK REVIEWER:

American Journal of Managed Care. 2019.

Currents in Pharmacy Teaching and Learning. 2018

Journal of the American College of Clinical Pharmacy. 2018-Present.

Journal of Obstetrics and Gynaecology. 2017.

Case Reports in Critical Care. Hindawi Publishing Corporation. 2016.

Powerpak CE. Reviewer for Neuroendocrine tumors: treatment of a diverse disease program. 2013-2016.

American Journal of Health-System Pharmacy. American Society of Health-System Pharmacists. 2013.

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. American College of Clinical Pharmacy. 2011.

Hospital Pharmacy. Thomas Land Publishers. 2011-Present.

Journal of Thrombosis and Haemostasis. International Society on Thrombosis and Haemostasis. 2011.

The Annals of Pharmacotherapy. Harvey Whitney Books Company. Cincinnati, OH. 2000-Present.

Pediatrics. American Academy of Pediatrics. Elk Grove Village, IL. 2009.

University Healthsystem Consortium Monograph Series. University HealthSystem Consortium. Oak Brook, IL. 2000-2008.

Doody Publishing Book Review Service. Oak Park, IL. 1999-2002.

Journal of Pharmacy Technology. Harvey Whitney Books Company. Cincinnati, OH. 2000.

FORMAL PRESENTATIONS:

Understanding biosimilar regulatory and legal concerns: impact on pharmacy practice. Continuing education webinar. Acurity. April 2020.

Intra-cerebrospinal fluid (CSF) administration of chemotherapy. Meiji University. Tokyo, Japan. January 2014.

Role of the drug information pharmacist at an academic medical center. Meiji University. Tokyo, Japan. January 2014.

Cost justification of a drug information pharmacist. American College of Clinical Pharmacy. Drug Information PRN Focus Session. Hollywood, FL. October 2012.

Adherence management – expanding the role of the pharmacist. Cardinal Retail Business Conference. Orlando, FL. July 2012.

Optimizing blood utilization: strategies for improving hemostatic practices. Focus on topical hemostats. 46th ASHP Midyear Clinical Meeting. Midday Symposium. New Orleans, LA. December 2011.

Drug information education: current status. American College of Clinical Pharmacy. Drug Information PRN Focus Session. Pittsburgh, PA. October 2011.

Thrombin and absorbable hemostatics. Illinois Council of Health-System Pharmacists and Missouri Council of Health-System Pharmacists. Spring Meeting. St. Louis, MO. April 2009.

Thrombin and absorbable hemostatics: understanding their position in healthcare institutions. Greater New York Hospital Association. New York, NY. July 2008.

Drug/herbal interactions. American Society of Enteral and Parenteral Nutrition. Chicago, IL. January 2001.

Consumer drug information. Drug Information Association Annual Meeting. San Diego, CA. May 2000.

New drug approvals. Illinois Council of Healthsystem Pharmacists/Illinois Pharmacists Association Spring Congress. Chicago, IL. March 1999.

Investigational biotechnology products. Resident seminar series. University of Illinois at Chicago College of Pharmacy. Chicago, IL. April 1999.

Development of a drug/nutrient interaction database. Great Lakes Regional Residents’ Conference. Lexington, KY. April 1999.

Phantom pain. Resident seminar series. University of Illinois at Chicago College of Pharmacy. Chicago, IL. October 1998.

Medication use evaluation of sedative agents in an adult ICU setting. Midwest Regional Residents’ Conference. Kansas City, MO. April 1998.

POSTERS:

Zych KV, Suda KJ, Griffin T, Tarlov E, Gerber B, Gabay M. Evaluation of the “gender gap” on editorial boards of leading medicine, pharmacy, and nursing journals. 2016 AACP Annual Meeting. Anaheim, CA. July 23 to 27, 2016.

Spencer S, Suda K, Gabay M. Publication rates and predictors of publication for abstracts presented at American Association of Colleges of Pharmacy (AACP) annual meetings. 2015 AACP Annual Meeting. National Harbor, MD. July 11 to 15, 2015.

Krueger C, Gabay M, Moody M. Evolution of the Drug Information Group at the UIC College of Pharmacy into a revenue generating business unit. 2015 American College of Clinical Pharmacy Global Meeting. San Francisco, CA. October 17 to 21, 2015.

Phillips J, May D, May R, Gabay M, et al. Drug Information Practice and Research Network needs assessment survey. 2014 American College of Clinical Pharmacy Meeting. Austin, TX. October 12 to 15, 2014.

Letarte N, Gabay MP, Bressler, LR, Stachnik JM, Villano JL. Analyzing temozolomide dosing errors: potentially fatal. 17th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Washington DC. November 15 to 18, 2012.

COMMITTEES:

Executive Committee. College of Pharmacy. 2020-Present.

Assessment Committee. College of Pharmacy. 2019-Present.

College of Pharmacy. Pharmacy Practice/Pharmacy and Systems Outcome Policy – Joint Planning Ad Hoc Committee. 2019.

College of Pharmacy. Strategic Planning Steering Committee. 2018.

Promotion and Tenure Committee. Department of Pharmacy Practice. 2018.

Residency Fellowship Evaluation Committee. Department of Pharmacy Practice. 2017.

Team Leader. Needs Assessment/Analysis Subgroup.

Promotion and Tenure Committee. Department of Pharmacy Practice. 2017.

Quality of Life Working Group Chair. Department of Pharmacy Practice. Strategic Planning. 2016.

Continuing Education Advisory Committee. Chair. 2015.

Department of Pharmacy Practice seminar series committee. Chair. 2014.

ACPE self-study. Organization and administration. Chair. 2014.

Curriculum Revision Steering Committee. Pre-requisite subcommittee. 2012.

Administrative Support Working Group Chair. Department of Pharmacy Practice. Strategic Planning. 2010.

Clinical Tenure Track Adhoc Committee. University of Illinois at Chicago. College of Pharmacy. Member. 2011.

Admissions committee. University of Illinois at Chicago. College of Pharmacy. Member. 2005, 2010-2012.

GPPA subcommittee.

Institutional Review Board #3. University of Illinois at Chicago. Member. 2007-2018.

Vice Chair – Institutional Review Board #3. 2011-2018.

ACPE accreditation sub-committee. University of Illinois at Chicago. College of Pharmacy. Member. 2007.

Resident Seminar committee. University of Illinois at Chicago. College of Pharmacy. Department of Pharmacy Practice. Member. 2004-2006.

MEDIA:

Interview on ReachMD. The evidence behind our clinical uses of IVIg. Hosted by: Charles Turck, PharmD. Available at: . April 2009.

Interview for Practical Pain Management. Oral fluid testing for codeine improves accuracy of clinical monitoring. Available at: . February 14, 2017.

SERVICE CONTRACTS:

Current Contracts

Chicago Diabetes Project. 2020-Present. Contract to assist in the development of a dossier on islet cell transplantation.

Visante, Inc. 2020-Present. Contract to plan and develop a consensus conference on surface contamination management.

Blue Cross Blue Shield Association. 2020-Present. Contract to revise medical policy documents.

Launchthat: 2019-Present. Contract to review medical/drug information on the site.

Backus Hospital: 2018-Present. Contract to answer drug information requests from hospital pharmacists at Backus

La Jolla Pharmaceuticals: 2018-Present. Contract to update AMCP-formatted dossiers for their available prescription products

ConsortiEX: 2018-Present. Contract to develop a database of injectable drug information for use in a medication workflow system

Conduent: 2018-Present. Contract to develop therapeutic class reviews in support of Missouri Medicaid

Athenex: 2018-Present. Contract to assist with medical information requests as needed

Lumere. 2017-Present. Contract to assist in the review and development of class reviews and also provide clinical support.

Fresenius Kabi. 2016-Present. Contract to develop and implement training programs for sales reps and to update existing and develop new AMCP-formatted drug dossiers

Healthcare and Family Services. 2016-Present. Contract to manage the provision of services related to the DocAssist program in conjunction with the University of Illinois at Chicago College of Medicine Department of Psychiatry.

Astellas. 2014-Present. Contract to develop AMCP-formatted dossiers, standard letters for Astellas products, and sales training slide kits.

Medical Insights Group. 2014-Present. Contract to complete various medical education projects.

Optum 2014-Present. Contract to update therapeutic class overviews.

MedAssets (now Vizient). 2013-Present. Contract to provide drug information services for all Vizient-affiliated hospitals and health systems.

Abelson Taylor. 2013-Present. Contract to provide clinical support services to a medical/pharmaceutical advertising firm as needed.

Postgraduate Health. 2013-Present. Contract to develop survey questions and needs assessments for educational programming.

Salveo Health Communications. 2012-Present. Contract for medical editing services.

Takeda Pharmaceuticals. 2011-Present. Contract to complete standard response letters, update medical communication documents, answer drug information requests, and update/develop AMCP dossiers.

Yale New Haven. 2012-Present. Contract to answer drug information requests from pharmacists at Yale New Haven hospitals.

Edward-Elmhurst Healthcare. 2010-Present. Contract for answering drug information requests from pharmacists at Edward-Elmhurst Healthcare.

El Camino Hospital. 2010-Present. Contract for answering drug information requests from pharmacists at El Camino Hospital.

ScrippsHealth. 2009-Present. Contract to answer drug information requests from ScrippsHealth pharmacists.

Healthcare and Family Services. 2006-Present. Contract with State of Illinois to provide prior authorization services, develop programs for implementation, and produce criteria for medication approval. Supervise an Assistant Director and 14.5 clinical staff pharmacists in the Prior Authorization Group. Also initiated a new unit, the Medical Review and Academic Detailing unit in 2012 to aid the State of Illinois in enforcing the 4 prescription policy for Medicaid patients, to review drug therapy of these patients, and provide education to Medicaid providers. This group has an Assistant Director and approximately 20 clinical staff pharmacists.

Healthcare and Family Services. 2004-Present. Contract to develop therapeutic class reviews, new drug reviews, and provide formulary support.

Cardinal Healthcare. 1999-Present. Annual contract to provide drug information support for approximately 300 hospital pharmacies nationwide. In addition, provide clinical support for the non-hospital pharmacy units of Cardinal and develop frequently asked questions for the Cardinal intranet as well as formulary class reviews.

University of Illinois at Chicago Medical Center. 1999 to present. Involved in writing or editing single drug and class reviews for the Medical Center, answering drug information requests from outpatient and inpatient pharmacists, and developing the bimonthly medical center newsletter.

Past Contracts

Ascension Health. 2015-2017. Contract to answer drug information requests from Ascension pharmacists.

Spectrum Health. 2012-2019. Contract to answer drug information requests from Spectrum Health pharmacists.

Healthline. 2015-2019. Contract to develop patient-focused drug information for an on-line site.

Pfizer. 2015-2017. Contract to develop and implement a formulary training certificate program.

Baxter. 2009-2017. Contract to plan and administer the once to twice yearly Baxter Pharmacy Customer Advisory Board.

PerformRX. 2016-2018. Contract to complete therapeutic class reviews.

Westchester County Medical Center. 2011-2017. Contract to answer drug information requests from pharmacists at Westchester County Medical Center.

MC-21. 1999-2017. Contract to develop drug class reviews for this health maintenance organization.

Apexus. 2015-2016. Contract to develop education activities and a “pipeline” around specialty products.

Abbott Laboratories. 2004. Developed journal club key points and questions to consider for clinical trials as part of a cardiovascular training project.

Advanced Neuromodulation Systems. 2008. Developed slide kits for physicians based on clinical articles in the area of spinal cord stimulation.

Advocate Healthcare. 2006-2007. Service contract to develop disease state and single drug reviews in the area of oncology.

Allscripts. 2011- 2012. Contract to provide comprehensive, fair-balanced clinical reviews of specific sponsored messaging embedded within Allscript’s ePrescribe software.

Amgen. 2010-2013. Contract to complete clinical efficacy and pharmacoeconomic study summaries for inclusion into the AMCP dossiers for Neupogen, Neulasta, and Prolia.

Aventis Behring. 2004. Developed frequently asked questions related to IVIG therapy for use within the company and for provision to customers.

Baxter. 2015. Contract to develop and plan a Medical Affairs Advisory Board for Baxter.

Baxter. 2009-2013. Contract to provide clinical support to the Clinical Planning and Operations sector of Baxter Healthcare.

Baxter. 2008. Participated in the coordination and organization of the Second Consensus Conference on IV Drug Delivery Systems. Contributed in the writing for both the pre- and post-papers for the Conference. Both papers have been published.

Baxter. 2007. Aided in the coordination of a 1 day nutrition training program for sales representatives and managers at the University of Illinois Medical Center at Chicago.

Baxter. 2007. Updated an investigational drug database involving injectable drugs in phases I to III of development.

Baxter. 2004. Developed a continuing medical education slide kit entitled: “IVIG use in autoimmune neurologic disease: clinical applications and therapeutic strategies.”

Baxter. 2004. Developed an initial Speaker’s Bureau for Baxter including content for slides the speakers could present. Initial planning meeting with the speakers was January 23 and 24, 2004.

Baxter. 2002. Developed article summaries and information for the Pulse web site. Pulse was a short-lived health drink marketed by Baxter. Information on the web site was related to the beneficial health effects of ingredients within Pulse.

Baxter. 2002-Present. Contract to moderate and develop materials related to the biannual Baxter Pharmacy Customer Advisory Board.

Baxter. 2002. Developed frequently asked questions on albumin as well as provided summaries of pertinent clinical articles related to blood products.

Baxter. 2002. Developed a slide kit related to the Molecular Absorbent Recirculating System (MARS).

Baxter. 2001. Developed 2 continuing education modules for Baxter on prophylactic therapy for hemophilia. Module 1 was entitled “Fundamentals of prophylaxis” and module 2 was entitled “Prophylaxis in clinical practice”.

Blue Shield of California. 1999-2004. Developed therapeutic drug class reviews.

Boehringer Ingelheim. 2009-2011. Contract to coordinate 2 separate programs on chronic obstructive pulmonary disease (COPD) and spirometry.

Boehringer Ingelheim and Illinois Health Education Consortium (IHEC). 2008. Service contract to develop content, present lectures, and coordinate a series of programs on respiratory disorders for physicians in rural areas of Illinois.

CareFusion. 2009-2011. Contract to provide drug information support for clinicians within CareFusion.

CareFusion. 2006-2012. Service contract to develop and edit over 400 drug entries for the smart pump library used in the CareFusion infusion pump system.

Chicago State University. 2009-2016. Contract to develop and implement a course for the second professional pharmacy year at Chicago State – PHAR 6222: Literature evaluation and evidence-based medicine.

Eli Lilly. 2009-2010. Contract to develop and implement a neurology-focused training program for sales reps.

Foundation for Continuing Professional Development. 2007-2010. Coordinate and develop continuing education modules for the web site. This site reached approximately 20,000 pharmacist and pharmacy technicians from a variety of state health-system pharmacy organizations.

HealthStrategy. 2010-2013. Contract to develop formulary class reviews.

Healthstream. 2008. Contract to update continuing education programs on a variety of topics including medication safety, medication administration, and blood products.

Hospira. 2015. Contract to develop an AMCP dossier for a biosimilar erythropoietin (Retacrit).

Hospira. 2008-2013. Contract to develop a training program, and participate in lectures within the program, in conjunction with the UIC Department of Anesthesiology in order to educate sales representatives and managers regarding the use of dexmedetomidine in anesthesia.

Medco/Express Scripts. 2009-2017. Developed and implemented live- and on-line training programs for community pharmacists in the areas of diabetes, cardiovascular disease, pulmonary disease, neuropsychiatry, and adherence.

Merck. 2008. Contract to develop, coordinate, and participate in a 1.5 day training program for Merck sales representatives in the area of diabetes.

Midwest Business Group on Health (MBGH). 2009. Partnership to provide class reviews, single drug reviews, and expert consultation related to medications to members of MBGH.

Neopharm. 2004-2006. Answered requests from patients regarding clinical trial site information for the PRECISE trial – a trial evaluating a treatment for glioblastoma.

Pharmedium. 2011-2015. Contract to provide medical information support, complete various drug information projects, and coordinate advisory board meetings.

Pharmedium. 2007. Participated in implementing a training program for Pharmedium sales representatives in the area of anesthesia with the aid of the UIC Department of Anesthesia.

ProCE. 2009. Contract to aid in developing a conference on hospital-acquired infections underwritten by Hospira. Contributed in the writing for both the pre- and post-papers for the conference.

RPh on the Go. 2006-2009. Developed continuing education programs for pharmacists that can be retrieved through the RPh on the Go web site. Participated in training programs for RPh on the Go pharmacy recruiters regarding clinical pharmacy.

UConn Health: 2014-2016. Answered drug information requests from pharmacists at UConn Health.

United Food and Commercial Workers Union. 2006-2010. Complete prior authorization requests related to montelukast usage and provide class reviews as needed.

University of Illinois at Chicago Continuing Education Office. 2006. Developed frequently asked questions and other content related to bioterrorism for a grant overseen by the Office of Academic Affairs.

Walgreens Health Initiatives. 2005-2011. Developed therapeutic drug class reviews.

WebMD. 2003-2008. Developed and updated medication information in patient “lay” language for the WebMD web site.

Wellpoint. 1999-2005. Developed therapeutic drug class reviews.

GRANTS:

PGY2 Residency in Drug Information funding grant from Abbvie. March 2016. $40,000.

PGY2 Residency in Drug Information funding grant from Takeda. February 2015. $96,200.

PGY2 Residency in Drug Information funding grant from Takeda. February 2014. $99,000.

PGY2 Residency in Drug Information funding grant from Abbvie. March 2015. $40,000.

PGY2 Residency in Drug Information funding grant from Abbvie. March 2014. $40,000.

PGY2 Residency in Drug Information funding grant from Abbvie. March 2013. $35,000.

PGY2 Residency in Drug Information funding grant from Abbott. March 2012. $35,000.

PGY2 Residency in Drug Information funding grant from Abbott. March 2011. $35,000.

PGY2 Residency in Drug Information funding grant from Abbott. March 2010. $49,000.

PGY2 Residency in Drug Information funding grant from Abbott. March 2009. $52,000.

AWARDS:

American College of Clinical Pharmacy Drug Information Practice and Research Network (ACCP DI PRN) Distinguished Drug Information Practitioner – 2016

Fellow of the American College of Clinical Pharmacy - 2017

PROFESSIONAL ASSOCIATIONS:

American Society of Health-System Pharmacists – member: 1993 to 2002; 2007-Present

Member: Section of Clinical Specialists and Scientist’s Educational Steering Committee Meeting Planning: 2017-2019

Chair and Moderator for ASHP Midyear 2018 Program: The Rise of Sexually Transmitted

Infections: an Alarming Trend of a Familiar Foe

Member: Section Advisory Group on Clinical Leadership: 2019-2020

American College of Clinical Pharmacy – full member: 1999-Present

Chair-Elect Drug Information PRN: 2010-2011

Chair Drug Information PRN: 2011-2012

Immediate Past Chair Drug Information PRN: 2012-2013

Chair: Publications Committee: 2015-2016

Member: Certification Affairs Committee: 2017-2018

Member: Clinical Pharmacy Challenge Item Writer’s Committee: 2017-2018

Member: Credentials: FCCP Committee: 2019-2021

Panelist: 2020 ACCP Pharmacotherapy Standard Setting Panel

Reviewer: Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Course: 2013

Reviewer: ACCP DI PRN - Student and resident travel awards: 2012-2013

Reviewer: Ambulatory Care Self-Assessment Program chapter “Drug Information and Electronic Resources”: 2016

Board of Pharmacy Specialties

Nonspecialist member: Pediatric Pharmacy Specialty Council: 2019-2021

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download